학술논문
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study).
Document Type
Article
Author
Source
Subject
*NEVIRAPINE
*HIGH density lipoproteins
*CORONARY heart disease risk factors
*THERAPEUTICS
*
*
*
Language
ISSN
1758-2652
Abstract
7-11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK [ABSTRACT FROM AUTHOR]